Cryotherapy reduces accommodation

Article

Eyes treated with peripheral retinal cryotherapy lose accommodative amplitude after surgery, according to results of a study published in the January 2009 issue of the American Journal of Ophthalmology.

Eyes treated with peripheral retinal cryotherapy lose accommodative amplitude after surgery, according to results of a study published in the January 2009 issue of the American Journal of Ophthalmology.

Tsuyoshi Uno of Ideta Eye Hospital, Kumamoto, Japan and colleagues examined eyes with retinal lattice degeneration (n=96) treated with cryotherapy between December 2001 and September 2004, and measured pre- and postoperative accommodative amplitudes.

Overall, researchers did not note any significant differences between pre- and postoperative accommodative amplitudes, although patients aged 10–29 years demonstrated decreased accommodative amplitudes when measured one and three weeks after treatment. Within this age bracket, this decrease was more significant in younger subjects, although, for all patients, accommodative amplitude returned to pretreatment levels by week six. The researchers also noted an association between acute loss of accommodation and cryotherapy numbers.

The researchers concluded that, although short-term losses in accommodation are possible, and more common in patients aged 10–29 years, these losses resolved within six weeks.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.